K, Wallace EM. Down syndrome screening: what do health professionals know? Aust N Z J Obstet Gynaecol 2003; 43 (3):217—21.
77
Carroll JC, et al. Ontario Maternal Serum Screening Program: practices, knowledge and opinions of health care providers. Can Med Assoc J 1997; 156 (6):775—84.
78
Wertz D. Drawing lines: notes for policymakers. In: Parens E, Asch A, eds. Prenatal testing and Disability Rights. Washington DC: Georgetown University Press, 2000:44—53.
79
de Crespigny L, Dredge R. Which Tests for my Unborn Baby? – Ultrasound and other prenatal tests. 2nd edn. Melbourne: Oxford University Press, 1996.
80
Cheng PJ, et al. Elevated maternal midtrimester serum free beta-human chorionic gonadotropin levels in vegetarian pregnancies that cause increased false-positive Down syndrome screening results. Am J Obstet Gynecol 2004; 190 (2):442—7.
81
Spencer K, et al. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Prenat Diagn 2004; 24 (3):169—73.
82
Watt HC, et al. Effect of allowing for ethnic group in prenatal screening for Down’s syndrome. Prenat Diagn 1996; 16 (8):691—8.
83
Abdul-Hamid S, et al. Maternal serum screening for trisomy 21 in women with a false positive result in last pregnancy. J Obstet Gynaecol 2004; 24 (4):374—6.
84
Spong CY, et al. Risk of abnormal triple screen for Down syndrome is signifi cantly higher in patients with female fetuses. Prenat Diagn 1999; 19 (4):337—9.
85
Wald NJ, et al. Maternal serum screening for Down’s syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Br J Obstet Gynaecol 1992; 99 (2):144—9.
86
Wapner R, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003; 349 (15):1405—13.
87
Wald NJ, et al. SURUSS in perspective. Br J Obstet Gynaecol 2004; 111 (6):521—31.
88
UK National Screening Programmes Committee Programmes Directorate. Screening for Down’s syndrome: Model of best practice (Appendix 3). In: National Down’s Syndrome Screening Programme for England. Oxford: UK National Screening Programmes Committee Programmes Directorate, 2004 www.nelh.nhs.uk/screening/dssp/Handbook_fi nal. pdf
89
Royal Australian and New Zealand College of Obstetricians and Gynecologists and Human Genetics Society of Australasia, March 2004. Antenatal Screening for Down Syndrome (DS) and other Fetal Aneuploidy. 2004.
90
U.S. Preventive Services Task Force. Screening Congenital Disorders: Screening for Down Syndrome. Guide to Clinical Preventive Services. 2nd edn. Rockville MD: Agency for Healthcare Research and Quality, 1996.
91
Centre for Disease Control. Economic Costs of Birth Defects and Cerebral Palsy – United States, 1992. Morbidity and Mortality Weekly Report 1995; 44 (37):694—9.
92
Cusick W, et al. Combined fi rst-trimester versus second-trimester serum screening for Down syndrome: a cost analysis. Am J Obstet Gynecol 2003; 188 (3):745—51.
93
Alfi revic Z, Neilson JP. Antenatal screening for Down’s syndrome. Br Med J 2004; 329 (7470):811—2, p 812.
94
Newnham JP, et al. Effects of repeated prenatal ultrasound examinations on childhood outcome up to 8 years of age: follow-up of a randomized controlled trial. Lancet 2004; 364 (9450):2038—44, p 2043.
95
Antsaklis AJ, et al. False positive serum biochemical screening and subsequent fetal loss in women less than 35 years of age. Br J Obstet Gynaecol 2001; 108 (6):589—93.
96
Papantoniou NE, et al. Risk factors predisposing to fetal loss following a second trimester amniocentesis. Br J Obstet Gynaecol 2001; 108 (10):1053—6.
97
Squier M, et al. Five cases of brain injury following amniocentesis in mid-term pregnancy. Dev Med Child Neurol 2000; 42 (8):554—60.
98
Squier M, et al. Five cases of brain injury following amniocentesis in mid-term pregnancy. Dev Med Child Neurol 2000; 42 (8):554—60.
99
Thompson PJ, et al. Lung function following fi rst-trimester amniocentesis or chorion villus sampling. Fetal Diagn Ther 1991; 6 (3—4):148—52.
100
Milner AD, et al. The effects of mid-trimester amniocentesis on lung function in the neonatal period. Eur J Pediatr 1992; 151 (6):458—60.
101
Greenough A, et al. Invasive antenatal procedures and requirement for neonatal intensive care unit admission. Eur J Pediatr 1997; 156 (7): 550—2.
102
Medda E, et al. Genetic amniocentesis: a risk factor for preterm delivery? Eur J Obstet Gynecol Reprod Biol 2003; 110 (2):153—8.
103
Enkin M, et al. Effective Care in Pregnancy and Childbirth. 3rd edn. Oxford: Oxford University Press, 2000.
104
Elchalal U, et al. Maternal
